Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Radiotherapy for myeloma]

H Nagoshi1, K Ide, H Suzuki

  • 1Third Department of Internal Medicine, St. Marianna University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytogenetic and molecular abnormalities in myelodysplastic syndrome.

Current molecular medicine·2011
Same author

p51/p63 Inhibits ultraviolet B-induced apoptosis via Akt activation.

Oncogene·2007
Same author

p53 homologue, p51/p63, maintains the immaturity of keratinocyte stem cells by inhibiting Notch1 activity.

Oncogene·2007
Same author

[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].

The Japanese journal of antibiotics·2000
Same author

Relations of vascular calcium channels with blood pressure and endothelium in hypertension and with aging.

Japanese heart journal·1999
Same author

Improved nitric oxide detection using 2,3-diaminonaphthalene and its application to the evaluation of novel nitric oxide synthase inhibitors.

Biological & pharmaceutical bulletin·1999
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Melphalan chemotherapy has improved myeloma patient survival and quality of life. Radiotherapy is best for pain relief in solitary plasmacytomas and palliative care in relapsed myeloma, not for improving overall survival.

Area of Science:

  • Oncology
  • Radiotherapy
  • Hematology

Context:

  • Melphalan chemotherapy has significantly improved outcomes for myeloma patients.
  • Myeloma is responsive to radiation, but its role in improving overall survival is limited.

Purpose:

  • To evaluate the role of radiotherapy in myeloma management, focusing on palliative care and pain relief.
  • To assess the efficacy and toxicity of different radiotherapy techniques in myeloma.

Summary:

  • Radiotherapy is indicated for relapsed/refractory myeloma and solitary plasmacytomas, primarily for pain palliation.
  • While total body irradiation has been used, newer techniques like hemibody and whole bone marrow irradiation aim to reduce toxicity.
  • Combining radiotherapy with chemotherapy has not shown improved survival compared to chemotherapy alone.

Related Experiment Videos

Impact:

  • Radiotherapy should be reserved for severe bone pain and lytic lesions in myeloma patients.
  • Optimized radiotherapy techniques can mitigate treatment-related toxicities.
  • The findings guide the judicious use of radiotherapy in myeloma treatment protocols.